Each delivery method involves trade-offs between convenience, bioavailability, cost, and personal preference
Whether public and private insurance plans should cover GLP-1 agonists when prescribed primarily for weight loss has been a significant topic of interest and debate
Another meta-analysis, which looked at relevant data from multiple clinical studies, estimated that 40-70% of people on GLP-1 drugs will experience nausea at some point while taking the medication
But he isnt using brand-name Wegovy or Zepbound
Injecting GLP-1 medications in the thigh is a safe, effective method for administering these diabetes and weight management treatments
The Wegovy pill is already available in pharmacies across the nation, with a starting cost of $150 a month for those without insurance coverage (going up to $300 a month for the larger dose many move up to)